Skip to main content
Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
29.14
-0.26 (-0.88%)
Nov 12, 2026, 4:00 PM EST - Market closed

Cogent Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-407.68-328.94-255.86-192.41-140.24-72.27
Depreciation & Amortization
4.924.584.353.595.881.99
Other Amortization
1.090.6----
Loss (Gain) From Sale of Assets
0.13--0.01--
Asset Writedown & Restructuring Costs
-----0.4-
Loss (Gain) From Sale of Investments
-3.11-1.96-7.62-5.17-1.64-
Stock-Based Compensation
66.6446.0839.7430.6218.3711.69
Other Operating Activities
7.187.18--1.7-1.36-0.34
Change in Accounts Payable
-10.09-2.511.364.812.362.75
Change in Other Net Operating Assets
16.8710.5210.246.63-1.61-2.58
Operating Cash Flow
-324.05-264.44-207.79-153.62-118.64-58.76
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.74-1.55-0.57-2.8-6.86-1.72
Investment in Securities
-305.9-397.9738.85-95.03-117.86-
Investing Cash Flow
-307.63-399.5338.28-97.82-124.72-1.72

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-272.39----
Long-Term Debt Repaid
--54.64----
Net Debt Issued (Repaid)
168.47217.76----
Issuance of Common Stock
633.47752.2214.45174.24174.3639.26
Repurchase of Common Stock
-48.9-48.9----
Other Financing Activities
-29.12-42.82--10.7-10.8-1.29
Financing Cash Flow
723.92878.23214.45163.54163.5637.98

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
92.24214.2644.94-87.91-79.8-22.51

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-325.78-266-208.36-156.42-125.5-60.48
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.98-2.06-2.00-1.96-2.13-1.56
Levered Free Cash Flow
-191.62-152.49-115.91-86.68-67.08-31.78
Unlevered Free Cash Flow
-189.61-151.18-115.91-86.68-67.08-31.78

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.442.02----
Change in Working Capital
6.788.0111.611.440.750.18
SEC Filings: 10-K · 10-Q